Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantern Pharma Inc. - Common Stock (NQ:LTRN)

4.348 -0.092 (-2.08%)
Streaming Delayed Price Updated: 3:06 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lantern Pharma Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Lantern Pharma Narrows Loss in Q2
Via The Motley Fool
Topics Artificial Intelligence
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Lantern Pharma's Earnings Outlook
 
Via Benzinga
Preview: Lantern Pharma's Earnings
 
Via Benzinga
Recap: Lantern Pharma Q4 Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
Lantern Pharma receives FDA clearance to begin Phase 1b/2 trial of LP-184 in advanced NSCLC patients with key mutations and low PD-L1 expression. 
Via Benzinga
Lantern Pharma Earnings Preview
 
Via Benzinga
Earnings Scheduled For May 15, 2025
 
Via Benzinga
EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial
Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations. 
Via Benzinga
Earnings Scheduled For March 27, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q2 2024
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
LTRN Stock Earnings: Lantern Pharma Misses EPS for Q1 2024
LTRN stock results show that Lantern Pharma missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire
Keep an eye on machine learning stocks. With big demand, we could be looking at a half-trillion-dollar market by 2030. 
Via InvestorPlace
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
No AI category went down in February, but 3 did in March - confirming my comment last week that 
Via Talk Markets
Topics Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial... 
Via Talk Markets
Topics Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.